Cannabis has been documented as the most commonly used illicit drug in Belgium by the European Monitoring Centre for Drugs and Drug Addiction’s 2018 report. Popular among young adults aged 15-34 years with males being the main users, cannabis is also the primary substance for clients entering drug treatment facilities in the country.

Research completed by 15 scientists from the University of Leuven and the University of Ghent reported that Belgium’s current cannabis policy is failing, with the number of drug dependant users and negative consequences continuing to increase.

Additionally, cocaine ranked first in 2018 for drugs seized and according to the Brussels Times, 39 tons of cocaine was intercepted by customs authorities at Antwerp Harbour in 2017. During a six-month period in 2018, 21.7 tons was already seized, a figure estimated to increase. As a result, the federal government have proposed an action plan to tackle the drug problem around the Antwerp Harbour.

As the need for vital drug screening continues to increase, Randox Toxicology are leading the way in developing new and novel drugs of abuse tests. Capable of detecting 21 classical, prescription and synthetic drugs from a single sample including cannabinoids and Benzoylecgonine, our fully automated Evidence MultiSTAT analyser utilises our Biochip Array Technology to deliver reliable and accurate results in under 20 minutes.

Make sure to drop by booth #B7 at TIAFT in Belgium from the 26th – 30th August 2018 to learn about our Evidence MultiSTAT and unrivalled toxicology test menu. Our team look forward to seeing you there!